Shaklee P N, Glaser J H, Conrad H E
J Biol Chem. 1985 Aug 5;260(16):9146-9.
Although 2-O-sulfated L-iduronic acid (IdoA) residues have been known to occur in heparin, 2-O-sulfated D-glucuronic acid (GlcA) residues have been reported only recently (Bienkowski, M. J., and Conrad, H. E. (1985) J. Biol. Chem. 250, 356-365). Disaccharides prepared by cleavage of heparin and N-deacetylated chondroitin 6-sulfate with nitrous acid were used to demonstrate a new sulfatase that catalyzed the removal of the 2-O-sulfate substituents from GlcA but not IdoA residues. The deamination products were labeled by NaB3H4 reduction to give disaccharides from heparin and chondroitin sulfate which had reducing terminal 2,5-anhydro-D-mannitol ([3H]AManR) and 2,5-anhydro-D-talitol ([3H]ATalR) residues, respectively. IdoA(2-SO4)-[3H]AManR(6-SO4) from heparin and GlcA(2-SO4)-[3H]ATalR(6-SO4) from chondroitin sulfate were purified for use as substrates. GlcA(2-SO4)-[3H]AManR(6-SO4) was prepared by epimerization of IdoA(2-SO4)-[3H]AManR(6-SO4) with hydrazine at 100 degrees C. Lysosomal enzyme preparations from chick embryo chondrocytes and from two normal human fibroblast cell lines catalyzed the removal of the 2-O-SO4 substituent from the uronic acid residues of IdoA(2-SO4)-[3H]AManR(6-SO4), GlcA(2-SO4)-[3H] AManR(6-SO4), and GlcA(2-SO4)-[3H]ATalR(6-SO4). In contrast, a lysosomal enzyme preparation from a human fibroblast cell line deficient in idurono-2-sulfatase (Hunter's-syndrome), which had no activity on the IdoA(2-SO4)-[3H]AManR(6-SO4), converted GlcA(2-SO4)-[3H]AManR(6-SO4) to a mixture of GlcA-[3H] AManR(6-SO4) and [3H]AManR(6-SO4). This enzyme also converted GlcA(2-SO4)-[3H]ATalR(6-SO4) to a mixture of GlcA-[3H]ATalR(6-SO4) and [3H]ATalR(6-SO4). Digestion of both GlcA(2-SO4)-[3H]AManR(6-SO4) and GlcA(2-SO4)-[3H]ATalR(6-SO4) was inhibited by 35SO2-4 and was arrested at the monosulfated disaccharide stage by 1,4-saccharolactone. The glucurono-2-sulfatase exhibited a pH optimum of 4. The results indicate that there exists a separate sulfatase for the removal of sulfate substituents from C-2 of GlcA residues in glycosaminoglycans.
虽然已知2 - O - 硫酸化的L - 艾杜糖醛酸(IdoA)残基存在于肝素中,但2 - O - 硫酸化的D - 葡萄糖醛酸(GlcA)残基直到最近才被报道(Bienkowski,M. J.,和Conrad,H. E.(1985)J. Biol. Chem. 250,356 - 365)。用亚硝酸裂解肝素和N - 脱乙酰化的硫酸软骨素6 - 硫酸酯制备的二糖用于证明一种新的硫酸酯酶,该酶催化从GlcA残基而非IdoA残基上去除2 - O - 硫酸酯取代基。脱氨产物通过NaB3H4还原进行标记,得到分别具有还原末端2,5 - 脱水 - D - 甘露糖醇([3H]AManR)和2,5 - 脱水 - D - 塔罗糖醇([3H]ATalR)残基的肝素和硫酸软骨素二糖。来自肝素的IdoA(2 - SO4)-[3H]AManR(6 - SO4)和来自硫酸软骨素的GlcA(2 - SO4)-[3H]ATalR(6 - SO4)被纯化用作底物。GlcA(2 - SO4)-[3H]AManR(6 - SO4)通过在100℃下用肼将IdoA(2 - SO4)-[3H]AManR(6 - SO4)差向异构化制备。来自鸡胚软骨细胞和两种正常人成纤维细胞系的溶酶体酶制剂催化从IdoA(2 - SO4)-[3H]AManR(6 - SO4)、GlcA(2 - SO4)-[3H] AManR(6 - SO4)和GlcA(2 - SO4)-[3H]ATalR(6 - SO4)的糖醛酸残基上去除2 - O - SO4取代基。相比之下,来自缺乏艾杜糖 - 2 - 硫酸酯酶(亨特综合征)的人成纤维细胞系的溶酶体酶制剂,对IdoA(2 - SO4)-[3H]AManR(6 - SO4)无活性,却将GlcA(2 - SO4)-[3H]AManR(6 - SO4)转化为GlcA - [3H] AManR(6 - SO4)和[3H]AManR(6 - SO4)的混合物。这种酶还将GlcA(2 - SO4)-[3H]ATalR(6 - SO4)转化为GlcA - [3H]ATalR(6 - SO4)和[3H]ATalR(6 - SO4)的混合物。GlcA(2 - SO4)-[3H]AManR(6 - SO4)和GlcA(2 - SO4)-[3H]ATalR(6 - SO4)的消化均受到35SO2 - 4的抑制,并被1,4 - 糖内酯阻滞在单硫酸化二糖阶段。葡萄糖醛酸 - 2 - 硫酸酯酶的最适pH为4。结果表明,存在一种单独的硫酸酯酶,用于从糖胺聚糖的GlcA残基的C - 2上去除硫酸酯取代基。